Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer

Published:2020-09 Issue:5 Volume:21 Page:455-463.e4
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Chiang Anne C.,Sequist Lecia Van Dam,Gilbert Jill,Conkling Paul,Thompson Dana,Marcoux J. Paul,Gettinger Scott,Kowanetz Marcin,Molinero Luciana,O’Hear Carol,Fassò Marcella,Lam Sivuonthanh,Gordon Michael S.

Funder

Roche

AstraZeneca

Novartis

Genentech

Boehringer Ingelheim

Merrimack Pharmaceuticals

Blueprint Medicines

Loxo Oncology

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data;Rossi;J Clin Oncol,2012

2. Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms;Stinchcombe;Oncologist,2010

3. Current standards for clinical management of small cell lung cancer;Farago;Transl Lung Cancer Res,2018

4. Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer;Socinski;J Clin Oncol,2009

5. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer;Rudin;Nat Genet,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Immune Checkpoint Inhibitors in Small Cell Lung Cancer;Science Discovery;2024-06-19

2. Unveiling FDA-Approved Drugs and Formulations in the Management of Bladder Cancer: A Review;Current Pharmaceutical Biotechnology;2024-05-23

3. Efficacy and safety of durvalumab + chemotherapy vs. atezolizumab + chemotherapy in the treatment of small-cell lung cancer: a retrospective comparative cohort study;Journal of Thoracic Disease;2023-06

4. Anticuerpos inmunomoduladores en el tratamiento del cáncer;Revista Repertorio de Medicina y Cirugía;2023-03-01

5. Neuroendocrine Tumors and Immune System;Interdisciplinary Cancer Research;2023